AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $979,000 | -11.6% | 27,958 | +35.0% | 0.01% | -14.3% |
| Q2 2020 | $1,107,000 | -91.9% | 20,706 | -95.1% | 0.01% | -90.9% |
| Q3 2019 | $13,594,000 | +163.6% | 419,574 | +305.8% | 0.08% | +140.6% |
| Q2 2019 | $5,157,000 | +1574.4% | 103,391 | +1446.8% | 0.03% | +966.7% |
| Q4 2018 | $308,000 | -99.1% | 6,684 | -98.4% | 0.00% | -97.3% |
| Q3 2018 | $32,556,000 | +30.7% | 422,138 | +42.7% | 0.11% | -20.6% |
| Q2 2018 | $24,912,000 | -10.1% | 295,758 | -12.7% | 0.14% | +1.4% |
| Q1 2018 | $27,707,000 | +106.4% | 338,794 | +44.3% | 0.14% | +87.8% |
| Q4 2017 | $13,425,000 | -15.9% | 234,825 | -1.5% | 0.07% | -26.7% |
| Q3 2017 | $15,972,000 | +4324.4% | 238,381 | +1483.5% | 0.10% | +1162.5% |
| Q4 2013 | $361,000 | -27.1% | 15,054 | -15.0% | 0.01% | -46.7% |
| Q3 2013 | $495,000 | – | 17,711 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |